Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Yuan Xie, Fangdi Hu, Dawei Xiang, Hui Lu, Wenbin Li, Anpeng Zhao, Longji Huang & Rong Wang. (2020) The metabolic effect of gut microbiota on drugs. Drug Metabolism Reviews 52:1, pages 139-156.
Read now
Read now
MarkA. Brown & StephenC. De Vito. (1993) Predicting azo dye toxicity. Critical Reviews in Environmental Science and Technology 23:3, pages 249-324.
Read now
Read now
King-Thorn Chung, S. Edward Stevens & Carl E. Cerniglia. (1992) The Reduction of Azo Dyes by the Intestinal Microflora. Critical Reviews in Microbiology 18:3, pages 175-190.
Read now
Read now
C.-E. Leijonmarck, P. Benno, B. Carlstedt-Duke, U. Monsen, E. Norin, B. Poppen, H. Saxerholt & T. Midtvedt. (1990) The Function of the Intestinal Microflora in Patients with Ulcerative Colitis before and after Colectomy. Scandinavian Journal of Gastroenterology 25:6, pages 585-593.
Read now
Read now
Hasse Schröder & Anna K. Johansson. (1973) Redox Potential in Caecal Contents of the Rat and Azo Reduction of Salicyl-Azo-Sulphapyridine. Xenobiotica 3:4, pages 233-246.
Read now
Read now
Articles from other publishers (27)
Lea Gnatzy, George Ismailos, Maria Vertzoni & Christos Reppas. (2023) Managing the clinical effects of drug-induced intestinal dysbiosis with a focus to antibiotics: Challenges and opportunities. European Journal of Pharmaceutical Sciences 188, pages 106510.
Crossref
Crossref
Jana Štofilová, Monika Kvaková, Anna Kamlárová, Emília Hijová, Izabela Bertková & Zuzana Guľašová. (2022) Probiotic-Based Intervention in the Treatment of Ulcerative Colitis: Conventional and New Approaches. Biomedicines 10:9, pages 2236.
Crossref
Crossref
Ana Rita da Silva Ferreira, Anne-Grete Märtson, Alyse de Boer, Hannah R. Wardill, Jan-Willem Alffenaar, Hermie J. M. Harmsen & Wim J. E. Tissing. (2021) Does Chemotherapy-Induced Gastrointestinal Mucositis Affect the Bioavailability and Efficacy of Anti-Infective Drugs?. Biomedicines 9:10, pages 1389.
Crossref
Crossref
Xintong Zhang, Ying Han, Wei Huang, Mingji Jin & Zhonggao Gao. (2021) The influence of the gut microbiota on the bioavailability of oral drugs. Acta Pharmaceutica Sinica B 11:7, pages 1789-1812.
Crossref
Crossref
Yukuang Guo, Hyunwoo Lee & Hyunyoung Jeong. 2020. The Microbiome in Health and Disease. The Microbiome in Health and Disease
61
93
.
Ian D. Wilson & Jeremy K. Nicholson. (2017) Gut microbiome interactions with drug metabolism, efficacy, and toxicity. Translational Research 179, pages 204-222.
Crossref
Crossref
Ian D. Wilson & Jeremy K. Nicholson. 2015. Metabonomics and Gut Microbiota in Nutrition and Disease. Metabonomics and Gut Microbiota in Nutrition and Disease
323
341
.
Steven R. Vigna. (2014)
5-Aminosalicylic Acid Inhibits Acute
Clostridium difficile
Toxin A-Induced Colitis in Rats
. International Journal of Inflammation 2014, pages 1-10.
Crossref
Crossref
Richard B. Silverman & Mark W. Holladay. 2014. The Organic Chemistry of Drug Design and Drug Action. The Organic Chemistry of Drug Design and Drug Action
357
422
.
Richard B. Silverman. 2004. The Organic Chemistry of Drug Design and Drug Action. The Organic Chemistry of Drug Design and Drug Action
405
495
.
Julio Gálvez, Margarita Garrido, Manuel Merlos, Maria Isabel Torres & Antonio Zarzuelo. (2009) Intestinal anti‐inflammatory activity of UR‐12746, a novel 5‐ASA conjugate, on acute and chronic experimental colitis in the rat. British Journal of Pharmacology 130:8, pages 1949-1959.
Crossref
Crossref
Stig Bondesen. (1997) INTESTINAL FATE OF 5-AMINOSALICYLIC ACID: REGIONAL AND SYSTEMIC KINETIC STUDIES IN RELATION TO INFLAMMATORY BOWEL DISEASE. Pharmacology & Toxicology 81, pages 1-30.
Crossref
Crossref
King-Thom Chung. 1997. Gastrointestinal Microbiology. Gastrointestinal Microbiology
511
582
.
L. -G. Axelsson & S. Ahlstedt. (1993) Actions of sulphasalazine and analogues in animal models of experimental colitis. Inflammopharmacology 2:3, pages 219-232.
Crossref
Crossref
M.Abu Shamat. (1993) The role of the gastrointestinal microflora in the metabolism of drugs. International Journal of Pharmaceutics 97:1-3, pages 1-13.
Crossref
Crossref
Richard B. Silverman. 1992. The Organic Chemistry of Drug Design and Drug Action. The Organic Chemistry of Drug Design and Drug Action
277
351
.
George Earl DukesJr.Jr.. 1992. Applied Therapeutics. Applied Therapeutics
397
410
.
Kenneth F. Ilett, Lisa B.G. Tee, Philip T. Reeves & Rodney F. Minchin. (1990) Mebolism of drugs and other xenobiotics in the gut lumen and wall. Pharmacology & Therapeutics 46:1, pages 67-93.
Crossref
Crossref
Hubert Allgayer, Niels O. Ahnfelt, Wolfgang Kruis, Ulrich Klotz, Katharina Frank-Holmberg, Hellmut N.A. Söderberg & Gustav Paumgartner. (1989) Colonic N-acetylation of 5-aminosalicylic acid in inflammatory bowel disease. Gastroenterology 97:1, pages 38-41.
Crossref
Crossref
J. R. S. Hoult. 1987. Side-Effects of Anti-Inflammatory Drugs. Side-Effects of Anti-Inflammatory Drugs
223
234
.
IAN R. ROWLAND. 1986. Bioreduction in the Activation of Drugs. Bioreduction in the Activation of Drugs
27
32
.
Ian R. Rowland. (1986) Reduction by the gut microflora of animals and man. Biochemical Pharmacology 35:1, pages 27-32.
Crossref
Crossref
J. R. S. Hoult & P. K. Moore. 1982. Inflammatory Bowel Diseases. Inflammatory Bowel Diseases
174
189
.
Henry J. Pieniaszek & Theodore R. Bates. (1979) Capacity-limited Gut Wall Metabolism of 5-aminosalicylic acid, a Therapeutically Active Metabolite of Sulfasalazine, in Rats. Journal of Pharmaceutical Sciences 68:10, pages 1323-1325.
Crossref
Crossref
G. C. Bolton & L. A. Griffiths. (1978) Metabolism of hydrazines and hydrazides by the intestinal microflora. Experientia 34:11, pages 1484-1486.
Crossref
Crossref
Peter Goldman & Mark A. Peppercorn. (1975) Sulfasalazine. New England Journal of Medicine 293:1, pages 20-23.
Crossref
Crossref
B. West, R. Lendrum, M. J. Hill & G. Walker. (1974) Effects of sulphasalazine (Salazopyrin) on faecal flora in patients with inflammatory bowel disease. Gut 15:12, pages 960-965.
Crossref
Crossref